Salicylic acid compositions and uses thereof
AssigneesPharmalp SA, UniversitäT Basel
InventorsPHILIPPE MEUWLY, OLIVIER POTTERAT, BRUNO SCHNYDER
Life of this patent
Estimating the term…
Abstract
The present invention is directed to compounds, compositions, uses and methods useful in the prevention or treatment of urinary infections, in particular E. coli infections and in particular recurrent urinary infections.
Claims23
1-21. (canceled)
An oral formulation comprising salicylic acid (SA) or a metabolite thereof or a mixture thereof, wherein said formulation comprises from about 0.75 μg to 2.6 mg of SA and at least one pharmaceutically or cosmetically acceptable carrier, diluent or excipient thereof, wherein said metabolite is a metabolite formed in vivo after ingestion of salicylic acid, for use for the prevention, repression and/or treatment of a urinary infection.
A formulation comprising salicylic acid (SA) or a metabolite thereof or a mixture thereof, said formulation further comprising at least one co-agent useful in the prevention and/or treatment urinary infections and at least one pharmaceutically or cosmetically acceptable carrier, diluent or excipient thereof, wherein said metabolite is a metabolite formed in vivo after ingestion of salicylic acid.
A method for preventing and/or treating a urinary infection in a subject, said method comprising administering by oral route in a subject in need thereof, an effective amount of salicylic acid (SA) or a metabolite thereof, or a mixture thereof or pharmaceutical compositions thereof, wherein said metabolite is a metabolite formed in vivo after ingestion of salicylic acid.
Dependencies are inferred from the claim text.